Cereno partners with CordenPharma to scale up CS1 drug production
Pharmaceutical Technology
JANUARY 12, 2024
Cereno Scientific has announced a partnership with CordenPharma to scale up manufacture of its drug candidate CS1.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
JANUARY 12, 2024
Cereno Scientific has announced a partnership with CordenPharma to scale up manufacture of its drug candidate CS1.
Bio Pharma Dive
APRIL 22, 2024
A partnership with Cellares, worth up to $380 million, is meant to help Bristol Myers speed and scale manufacture of the complex cellular treatments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 30, 2024
Increasing the production capacity for Zepbound and Mounjaro is “the most ambitious expansion plan in our company’s history,” said CEO David Ricks.
BioPharma Reporter
AUGUST 17, 2020
Dynavax gets Bill & Melinda Gates Foundation funding to scale up production of adjuvant for use in COVID-19 vaccines.
Pharmaceutical Technology
MARCH 13, 2024
In T-cell manufacturing, the historical issue of maintaining the quality of materials when scaling up production is changing.
Drug Discovery World
MARCH 14, 2023
By partnering with a supplier like Thermo Fisher Scientific, you gain access to end-to-end mRNA workflow solutions, products with proven quality, and technical professionals who can proficiently support you throughout your process development and scale-up stages.
XTalks
AUGUST 17, 2023
New Culture, one of several emerging startups using precision fermentation to produce casein proteins, has scaled up its fermentation process to now make manufacturing volumes, specifically for its animal-free mozzarella. These investments, totalling $28.5 These investments, totalling $28.5
Fierce Pharma
NOVEMBER 22, 2023
Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing production of diabetes drug Victo | Unable to scale up its manufacturing fast enough to meet the spiraling demand for its GLP-1 weight loss products, Novo Nordisk is employing a new strategy—reducing (..)
BioSpace
SEPTEMBER 12, 2023
The company plans to launch up to 15 new products and bring up to 50 new candidates to the clinic over the next five years as part of its growth plan, while scaling down COVID-19 manufacturing.
pharmaphorum
APRIL 6, 2022
The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company.
BioPharma Reporter
AUGUST 24, 2021
Swedenâs Biotage says its expanded facility in the UK will allow it to triple its production capacity for equipment crucial in the supply chain for the production of mRNA vaccines, and thus eliminating a bottleneck for COVID-19 vaccines.
Fierce Pharma
MAY 15, 2024
following | Galapagos has teamed up with the largest blood supply network in the U.S. to help establish decentralized CAR-T production on a national scale.
The Pharma Data
MARCH 20, 2021
Fermentation is used in the production of renewable feedstocks for food products and ingredients, beverages, pharmaceutical compounds, nutraceuticals, through to fine and bulk chemicals. In this regard, Martin Hoogedoorn, Product Specialist at Elscolab Nederland B.V., Faster scale-up.
XTalks
NOVEMBER 29, 2023
This collaboration is set to usher in a new era of sustainable and nutritious protein production, leveraging Ginkgo Bioworks’ expertise in cell programming and biosecurity. This process ensures optimal protein expression and functionality at a commercial scale. Ginkgo Bioworks has vast experience partnering with food tech firms.
Drug Discovery World
MAY 7, 2024
Where the bottlenecks of achieving higher cell density and higher titers were once thought to be issues of the past, hurdles have now shifted to achieving speed and scale in mAb production without sacrificing quality. DC: Antibodies have and remain a large product class within the biopharmaceutical market.
Fierce Pharma
NOVEMBER 15, 2023
. | After reporting a sizable revenue decline for its BMS-parntered multiple myeloma cell therapy in 2023’s third quarter, 2seventy stands out as a prime example of the dangers of scaling up a process before suffering lower-than-expected demand, one group of analysts contends.
Pharmaceutical Technology
AUGUST 2, 2022
Samsung Biologics and GreenLight Biosciences have completed the initial commercial-scale engineering run for their messenger ribonucleic acid (mRNA) Covid-19 vaccine under their manufacturing collaboration. Furthermore, the mRNA synthesis reaction of GreenLight had a titer of 12g/L at a commercial scale and yielded 650g mRNA.
BioTech 365
JANUARY 12, 2021
Lestrem and Zwingenberg, 13th January 2021 Roquette and BRAIN Group agree on production scale-up … Continue reading → Biotechnology Research And Information Network AG / Key word(s): Agreement 13.01.2021 / 08:00 The issuer is solely responsible for the content of this announcement.
BioTech 365
DECEMBER 22, 2020
Genprex Completes Manufacturing Scale-Up for Clinical-Grade Production of REQORSA™ Immunogene Therapy for Upcoming Acclaim-1 and Acclaim-2 Clinical Trials For Lung Cancer Genprex Completes Manufacturing Scale-Up for Clinical-Grade Production of REQORSA™ Immunogene Therapy for Upcoming Acclaim-1 and Acclaim-2 Clinical Trials For … (..)
Drug Discovery World
NOVEMBER 27, 2023
A complex journey Biotherapeutics discovery and development upstream encounters challenges in cell line development (CLD), clone screening and characterisation, scale up, and eventually production. Stable clonal cell banks are used for GMP production of the final drug product. Metab Eng 2020;57:203.
BioPharma Reporter
MAY 24, 2023
Purolite, an Ecolab company based in Pennsylvania, is a leading manufacturer of healthcare, pharmaceutical and life science products. The company is concerned with projects involving purification of mRNA vaccines and monoclonal antibodies for cancer-treatment drugs, among others.
Pharma Mirror
MAY 31, 2023
In the face of increasing global health challenges, the development and production of vaccines have become paramount. One critical aspect is the ability to scale up manufacturing processes to meet the growing demand for viral vector-based vaccines.
Drug Discovery World
OCTOBER 3, 2022
Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. Biosynth can ensure your project succeeds first time, with innovative expertise across chemistry and peptides.
pharmaphorum
DECEMBER 4, 2020
Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. A Pfizer spokesperson told Reuters that the “scale-up of the raw material supply chain took longer than expected”. million doses.
Pharmaceutical Technology
SEPTEMBER 7, 2022
Bharat Biotech carried out the product development linked to preclinical safety assessment, large-scale production scale-up, as well as the development of formulation and delivery device, including trials in humans. iNCOVACC has been designed for efficient distribution and easy administration.”.
XTalks
MAY 27, 2021
To help boost production of its COVID-19 vaccine, Moderna has enlisted the services of Samsung Biologics , a contract development and manufacturing organization (CDMO) based in South Korea. Last month, Moderna announced it is upping its COVID-19 vaccine targets, aiming for 800 million to 1 billion doses this year and 3 billion doses by 2022.
Drug Discovery World
AUGUST 22, 2023
Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost. Complex generics comprise a diverse range of products.
Pharmaceutical Technology
NOVEMBER 24, 2022
Additionally, the transfer of technology will build and validate capacity for scaling up Good Manufacturing Process (GMP), domestic production of clinical trial products and end-to-end vaccine manufacturing in Africa for regional and global use.
Pharmaceutical Technology
AUGUST 25, 2022
Sonoma Biotherapeutics has signed a lease agreement for setting up an 83,000ft² research and development (R&D) and manufacturing centre for cell therapies. A cGMP-compliant production facility will be housed at the centre for manufacturing cell products at scale.
STAT News
JANUARY 17, 2023
We hope your day is productive and meaningful. … After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back efforts to produce the shots as it faces slumping demand , The Wall Street Journal reports. government, has not lived up to expectations.
Pharma Mirror
SEPTEMBER 19, 2021
With this agreement, HTL will exclusively develop, scale-up, and supply a high-grade functional injectable Hyaluronic Acid based active ingredient, Sodium Hyaluronate Lipoate Formate (SHLF), for a major part of BMG Pharma’s products.
Pharmaceutical Technology
SEPTEMBER 28, 2022
Chimerix entered a ten-year contract worth up to $680m with the US Government in August this year for delivering up to 1.7 Apart from product purchase, the contract also includes $12m worth of reimbursed post-marketing activities. Emergent will also make a further payment of up to $12.5m
Pharmaceutical Technology
APRIL 6, 2023
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted ADvantage Therapeutics’ immunotherapy AD04 an Innovation Passport for the treatment of Alzheimer’s disease. A recent wave of monoclonal antibodies, including the FDA-approved Eisai / Biogen ’s Leqembi (lecanemab), is expected to shake up the space.
Drug Discovery Today
JANUARY 13, 2020
The novel silicon chip is a key component of Evonetix’s desktop DNA platform which, once fully developed, will facilitate and enable the rapidly growing field of synthetic biology.
Scienmag
JULY 14, 2021
Credit: The University of Texas at Austin Urea is a critical element found in everything from fertilizers to skin care products. Large-scale production of urea, which is naturally a product of human urine, is a massive undertaking, making up about 2% of global energy use and emissions today.
pharmaphorum
FEBRUARY 14, 2022
A recent report has found that R&D productivity rose vertiginously during 2021, but how much of this was organic and how much can be attributed to the pandemic? The pandemic also saw a reduction in the overall development cycle of a product, which has been growing in recent years. In 2020, the development cycle averaged 7.14
Pharmaceutical Technology
MAY 17, 2023
AGC Biologics has introduced the BravoAAV and ProntoLVV viral vector platforms that offer quick clinical and commercial production and release of good manufacturing practices (GMP). The new platforms have production at various scales in suspension and adhesion up to 2,000l and 750l, respectively.
Drug Discovery World
MARCH 22, 2023
Download this eBook to learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications.
Pharmaceutical Technology
MARCH 31, 2023
The company will construct the new advanced mRNA facility, which is claimed to be Moderna’s first mRNA manufacturing facility in Africa and is expected to have the capacity to produce up to 500 million vaccine doses annually.
pharmaphorum
OCTOBER 18, 2022
One of the first actions by GSK’s recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma’s R&D productivity, starting with its cancer pipeline. The post GSK turns to AI specialist Tempus for R&D productivity boost appeared first on.
Pharmaceutical Technology
MAY 25, 2023
ElevateBio has raised $401m in a Series D financing round for advancing its technology platforms to expedite the design, production and development of cell and gene therapies. The partnership will enable the development of up to seven programmes.
Drug Discovery Today
JULY 13, 2020
CPI today announced a partnership with Excivion Ltd, Cambridge, to optimise the manufacture of their novel Zika vaccine antigen candidate, Zika-HX, an integral component of any future vaccine formulation.
Pharmaceutical Technology
JULY 18, 2022
With the ever-rising costs of bringing a drug to market, pharmaceutical companies are increasingly looking at how they can improve the efficiency of their entire product development and drug commercialisation process. And these are just a few of the surprise challenges that a manufacturer might face during scale-up.
Drug Discovery World
MARCH 22, 2023
Download the eBook to learn more about process development and manufacturing in the mRNA space to enable successful scale-ups of mRNA production for therapeutic applications.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content